Author(s): Iyoda A, Makino T, Koezuka S, Otsuka H, Hata Y
Abstract Share this page
Abstract Large cell neuroendocrine carcinoma (LCNEC) of the lung is categorized as a variant of large cell carcinomas, and LCNEC tumors display biological behaviors resembling those of small cell lung carcinomas and features of high-grade neuroendocrine tumors. Because patients with LCNEC have a poor prognosis, surgery alone is not sufficient. Multimodality therapies, including adjuvant chemotherapy, appear promising for improved prognosis in patients with LCNEC. In this review article, we discuss treatment options for patients with LCNEC of the lung.
This article was published in Gen Thorac Cardiovasc Surg
and referenced in Journal of Orthopedic Oncology